Get the Stockscreener App
2.24
1.75%
-0.04
Ventyx Biosciences Inc Stock (VTYX) Forecast
The Ventyx Biosciences Inc (VTYX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $3.1753, representing a +41.76% increase from the current price of $2.24. The highest analyst price target is $6.0895, and the lowest is $0.2612.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month VTYX Price Target
Average 19.06
(+751.09% Upside)
Is Ventyx Biosciences Inc (VTYX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 45.92 | Neutral |
| STOCH(9,6) | 5.6439 | Buy |
| STOCHRSI(14) | 3.6201 | Buy |
| MACD(12,26) | 0.0192 | Sell |
| ADX(14) | 22.80 | Neutral |
| William %R | -97.05 | Buy |
| CCI(14) | -50.16 | Neutral |
Buy: 3
Sell: 1
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.456
Sell
|
2.3786
Sell
|
| MA20 |
2.477
Sell
|
2.3867
Sell
|
| MA50 |
2.2928
Sell
|
2.332
Sell
|
| MA100 |
2.2196
Buy
|
2.5606
Sell
|
| MA200 |
3.2576
Sell
|
4.47
Sell
|
Buy: 1
Sell: 9
Neutral: 0
Summary: Sell
According to our latest analysis, VTYX could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 10 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on VTYX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 45.92 indicates that VTYX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 5.6439 indicates that VTYX is oversold. This indicates that VTYX price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 3.6201 indicates that VTYX is oversold. This suggests that VTYX price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 22.8 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -50.16 indicates that VTYX is still oversold but not to an extreme extent.
Long-term VTYX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Ventyx Biosciences Inc financial reports and earnings history, Ventyx Biosciences Inc (VTYX) stock could reach $3.5231 by 2030, $28.93 by 2040 and $31.96 by 2050. See the projected annual prices until 2050 of the Ventyx Biosciences Inc stock below:
- Ventyx Biosciences Inc (VTYX) is expected to reach an average price of $6.5586 in 2035, with a high prediction of $6.8786 and a low estimate of $0.3812. This indicates an $192.79% rise from the last recorded price of $2.24.
- Ventyx Biosciences Inc (VTYX) stock is projected to chart a bullish course in 2040, with an average price target of $29.06, representing an $1,197% surge from its current level. The forecast ranges from a conservative $32.41 to a sky-high $28.93.
- Our analysts predict Ventyx Biosciences Inc (VTYX) to jump 4,026% by 2045, soaring from $94.03 to an average price of $92.43, potentially reaching $92.72. While $94.03 is the low estimate, the potential upside is significant.
- Ventyx Biosciences Inc (VTYX) stock is expected to climb by 2050, reaching an average of $31.80, a $1,320% jump from its current level. However, a wide range of estimates exists, with high and low targets of $31.96 and $31.85, respectively, highlighting the market's uncertainty.
Ventyx Biosciences Inc Stock (VTYX) Year by Year Forecast
Ventyx Biosciences Inc Stock (VTYX) Price Forecast for 2025
Ventyx Biosciences Inc Stock (VTYX) is expected to reach an average price of $19.06 in 2025, with a high prediction of $37.87 and a low estimate of $0.2612. This indicates an +751.09% rise from the last recorded price of $2.24.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $0.5388 | $0.2612 | $6.0895 | -75.95% |
| February, 2025 | $2.5382 | $0.3442 | $4.2182 | +13.31% |
| March, 2025 | $6.0775 | $0.4405 | $6.6575 | +171.32% |
| April, 2025 | $11.33 | $6.0699 | $15.55 | +405.77% |
| May, 2025 | $22.79 | $20.89 | $29.60 | +917.35% |
| June, 2025 | $21.26 | $14.51 | $23.41 | +849.01% |
| July, 2025 | $18.29 | $13.03 | $22.83 | +716.50% |
| August, 2025 | $21.12 | $13.84 | $26.55 | +842.81% |
| September, 2025 | $24.11 | $18.62 | $25.47 | +976.26% |
| October, 2025 | $34.69 | $23.41 | $35.86 | +1,449% |
| November, 2025 | $29.92 | $29.59 | $37.87 | +1,236% |
| December, 2025 | $20.96 | $18.86 | $31.86 | +835.76% |
Ventyx Biosciences Inc Stock (VTYX) Price Forecast for 2026
The predicted value for Ventyx Biosciences Inc (VTYX) in 2026 is set at an average of $16.85. Estimates vary from a peak of $32.76 to a trough of $0.9326, indicating an +652.10% surge from the present price of $2.24.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $26.34 | $22.49 | $31.16 | +1,076% |
| February, 2026 | $25.77 | $24.62 | $29.26 | +1,050% |
| March, 2026 | $24.90 | $23.06 | $28.04 | +1,012% |
| April, 2026 | $29.56 | $25.41 | $32.76 | +1,220% |
| May, 2026 | $24.22 | $22.11 | $29.95 | +981.26% |
| June, 2026 | $29.57 | $24.32 | $30.54 | +1,220% |
| July, 2026 | $10.77 | $10.12 | $31.45 | +380.86% |
| August, 2026 | $3.6945 | $3.7695 | $10.66 | +64.93% |
| September, 2026 | $3.4678 | $3.5878 | $3.5301 | +54.81% |
| October, 2026 | $3.0184 | $3.0684 | $3.1531 | +34.75% |
| November, 2026 | $2.9091 | $3.0391 | $3.0014 | +29.87% |
| December, 2026 | $2.4726 | $0.9326 | $4.2325 | +10.38% |
Ventyx Biosciences Inc Stock (VTYX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Ventyx Biosciences Inc (VTYX) is $8.5863, with a high forecast of $17.17 and a low forecast of $0.00169. This indicates an +283.32% increase from the last price of $2.24.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $2.4219 | $2.3719 | $7.0373 | +8.12% |
| February, 2027 | $0.5213 | $0.2863 | $2.8143 | -76.73% |
| March, 2027 | $8.8053 | $0.00169 | $9.94 | +293.09% |
| April, 2027 | $13.12 | $11.42 | $11.42 | +485.56% |
| May, 2027 | $10.60 | $14.50 | $13.71 | +373.12% |
| June, 2027 | $13.37 | $14.88 | $13.86 | +497.08% |
| July, 2027 | $17.45 | $17.81 | $17.17 | +678.83% |
| August, 2027 | $17.68 | $16.47 | $16.89 | +689.16% |
| September, 2027 | $14.30 | $15.12 | $15.16 | +538.56% |
| October, 2027 | $11.93 | $13.04 | $10.73 | +432.37% |
| November, 2027 | $8.6664 | $9.2857 | $7.8854 | +286.89% |
| December, 2027 | $12.71 | $11.53 | $12.64 | +467.54% |
Ventyx Biosciences Inc Stock (VTYX) Price Forecast for 2028
In 2028, Ventyx Biosciences Inc (VTYX) is projected to reach an average price of $15.20, with a high projection of $28.48 and a low estimate of $1.9116. This indicates an +578.49% rise from the last price of $2.24.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $9.5843 | $10.61 | $10.71 | +327.87% |
| February, 2028 | $2.9356 | $3.0956 | $7.9696 | +31.05% |
| March, 2028 | $10.40 | $1.9116 | $17.91 | +364.19% |
| April, 2028 | $5.2165 | $3.2365 | $15.66 | +132.88% |
| May, 2028 | $4.5199 | $2.1452 | $11.80 | +101.78% |
| June, 2028 | $6.0786 | $3.3036 | $8.5739 | +171.36% |
| July, 2028 | $11.77 | $5.6032 | $16.09 | +425.32% |
| August, 2028 | $24.31 | $11.41 | $25.00 | +985.30% |
| September, 2028 | $24.32 | $20.59 | $26.23 | +985.69% |
| October, 2028 | $16.33 | $14.30 | $28.48 | +628.93% |
| November, 2028 | $20.15 | $9.9721 | $22.42 | +799.62% |
| December, 2028 | $17.67 | $16.14 | $22.60 | +688.85% |
Ventyx Biosciences Inc Stock (VTYX) Price Forecast for 2029
The 2029 price forecast for Ventyx Biosciences Inc Stock (VTYX) is $12.88 on average, with a high prediction of $24.94 and a low estimate of $0.8255. This represents an +475.19% increase from the previous price of $2.24.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $16.81 | $15.52 | $19.89 | +650.60% |
| February, 2029 | $20.45 | $15.16 | $24.94 | +813.04% |
| March, 2029 | $18.75 | $16.36 | $23.02 | +737.09% |
| April, 2029 | $19.76 | $14.87 | $20.25 | +782.13% |
| May, 2029 | $17.10 | $14.46 | $24.70 | +663.53% |
| June, 2029 | $1.9117 | $1.517 | $17.20 | -14.66% |
| July, 2029 | $9.4096 | $1.6864 | $9.4743 | +320.07% |
| August, 2029 | $8.8162 | $8.9562 | $9.2903 | +293.58% |
| September, 2029 | $8.3975 | $8.3822 | $8.2416 | +274.89% |
| October, 2029 | $7.0842 | $7.3142 | $8.1029 | +216.26% |
| November, 2029 | $1.0345 | $0.8255 | $2.5945 | -53.81% |
| December, 2029 | $3.3868 | $1.9008 | $2.3468 | +51.19% |
Ventyx Biosciences Inc Stock (VTYX) Price Forecast for 2030
Ventyx Biosciences Inc Stock (VTYX) is expected to reach an average price of $17.61 in 2030, with a high forecast of $31.66 and a low forecast of $3.5621. This signifies an +686.18% surge from the last price of $2.24.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $3.5426 | $3.5621 | $3.5231 | +58.15% |
| February, 2030 | $24.86 | $27.23 | $25.91 | +1,010% |
| March, 2030 | $31.70 | $28.06 | $29.11 | +1,315% |
| April, 2030 | $29.46 | $29.73 | $28.83 | +1,215% |
| May, 2030 | $31.94 | $29.70 | $30.75 | +1,326% |
| June, 2030 | $29.46 | $31.48 | $31.66 | +1,215% |
| July, 2030 | $28.28 | $29.03 | $29.38 | +1,163% |
| August, 2030 | $26.22 | $28.25 | $27.38 | +1,070% |
| September, 2030 | $21.01 | $22.54 | $23.02 | +837.88% |
| October, 2030 | $25.14 | $22.53 | $24.41 | +1,022% |
| November, 2030 | $22.49 | $23.94 | $25.32 | +903.81% |
| December, 2030 | $18.29 | $20.31 | $20.94 | +716.40% |
2.88%
2.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):